
HRT and the FDA
The Brian Lehrer Show
00:00
Navigating the Controversies of Hormone Therapy Warnings
This chapter explores the debates around the removal of black box warnings on hormone therapy, highlighting political motives and pharmaceutical influences. It underscores the need for critical analysis of health policies and the impact of financial interests on medical research and regulation.
Transcript
Play full episode